Holen Sie sich die Stockscreener-App
98.66
0.50%
0.49
Handel nachbörslich:
98.66
Schlusskurs vom Vortag:
$98.17
Offen:
$97.93
24-Stunden-Volumen:
6.74M
Relative Volume:
1.26
Marktkapitalisierung:
$145.41B
Einnahmen:
$15.91B
Nettoeinkommen (Verlust:
$1.79B
KGV:
81.54
EPS:
1.21
Netto-Cashflow:
$1.89B
1W Leistung:
+3.98%
1M Leistung:
+9.10%
6M Leistung:
+27.45%
1J Leistung:
+61.84%
1-Tages-Spanne:
$97.68
$99.14
1-Wochen-Bereich:
$93.20
$99.14
52-Wochen-Spanne:
$59.85
$99.14
Boston Scientific Corp Stock (BSX) Company Profile
Firmenname
Boston Scientific Corp
Sektor
Branche
Telefon
508-683-4000
Adresse
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Vergleichen Sie BSX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Herabstufung | Needham | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2024-02-01 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2022-12-22 | Eingeleitet | Mizuho | Neutral |
| 2022-12-20 | Fortgesetzt | Citigroup | Buy |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-07-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-05-27 | Hochstufung | Needham | Hold → Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-05-26 | Herabstufung | Needham | Buy → Hold |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-17 | Eingeleitet | Truist | Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-04-22 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Hochstufung | Goldman | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Neutral |
| 2020-02-06 | Fortgesetzt | BTIG Research | Buy |
| 2019-12-30 | Bestätigt | Cowen | Outperform |
| 2019-12-19 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-09-05 | Fortgesetzt | JP Morgan | Overweight |
| 2019-09-03 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-10-02 | Bestätigt | Morgan Stanley | Overweight |
| 2018-09-07 | Bestätigt | Needham | Strong Buy |
| 2018-09-04 | Hochstufung | Jefferies | Hold → Buy |
| 2018-07-06 | Bestätigt | Needham | Strong Buy |
| 2018-06-27 | Eingeleitet | Bernstein | Outperform |
| 2018-04-26 | Bestätigt | Needham | Strong Buy |
Alle ansehen
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
RBC Capital holds Boston Scientific stock Outperform rating - MSN
Top 10 Medical Device Predictions for 2025 - GlobeNewswire Inc.
Avanza Fonder AB Takes $14.41 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
RBC Capital holds Boston Scientific stock Outperform rating By Investing.com - Investing.com Australia
Empirical Asset Management LLC Buys Shares of 16,204 Boston Scientific Co. (NYSE:BSX) - MarketBeat
TD Cowen maintains Boston Scientific buy rating, $110 target - Investing.com
Boston Sci reports good data for Farapulse, Watchman afib systems - BioWorld Online
Boston Scientific reaches preliminary settlement By Investing.com - Investing.com Canada
Boston Scientific data supports Farapulse, Watchman FLX - Mass Device
Boston Scientific (BSX) Receives Preliminary Approval for Shareh - GuruFocus.com
Boston Scientific reaches preliminary settlement - Investing.com India
Boston Scientific's WATCHMAN FLX Shows 62% Bleeding Reduction, FARAPULSE Trial Hits Safety Goals - StockTitan
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Gateway Investment Advisers LLC Decreases Stock Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Hennion & Walsh Asset Management Inc. Buys 7,618 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Assenagon Asset Management S.A. Has $84.77 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
2,735 Shares in Boston Scientific Co. (NYSE:BSX) Bought by Claro Advisors LLC - MarketBeat
Moody National Bank Trust Division Makes New $249,000 Investment in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Corp. stock rises Wednesday, still underperforms market - MarketWatch
Boston Scientific (NYSE:BSX) Reaches New 52-Week HighHere's Why - MarketBeat
Boston Scientific stock soars to all-time high of $97.13 - Investing.com
Brendel Financial Advisors LLC Purchases New Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Board of the Pension Protection Fund Invests $1.02 Million in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Pines Wealth Management LLC Acquires New Stake in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Sold by Community Trust & Investment Co. - MarketBeat
Boston Scientific expects Farapulse, Watchman to drive 2025 growth - Mass Device
Boston Scientific (LTS:0HOY) 3-Year Revenue Growth Rate : 11.60% (As of Sep. 2024) - GuruFocus.com
Boston Scientific stock retains Buy rating on financial guidance - Investing.com
Brookstone Capital Management Buys 20,307 Shares of Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance UK
Courier Capital LLC Has $2 Million Position in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Why Boston Scientific (BSX) is Skyrocketing in 2025? - Insider Monkey
Salem Investment Counselors Inc. Has $17.58 Million Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
2 Newly Overvalued Stocks - Morningstar
Czech National Bank Boosts Holdings in Boston Scientific Co. (NYSE:BSX) - MarketBeat
Boston Scientific Co. (NYSE:BSX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Boston Scientific Completes $1.7 Billion Offering Of Senior Notes - Reuters.com
Here’s Why Boston Scientific Corp. (BSX) Skyrocketed Today - MSN
Boston Scientific announces acquisition of the remaining stake in Bolt Medical - MSN
Boston Scientific price target raised to $110 from $100 at Bernstein - MSN
BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement - MSN
Boston Scientific (NYSE:BSX) Raised to "Buy" at Deutsche Bank Aktiengesellschaft - MarketBeat
Deutsche Bank lifts Boston Scientific stock rating to Buy, says execution is hard - Investing.com
Boston Scientific's SWOT analysis: medtech giant's stock poised for growth By Investing.com - Investing.com Australia
Truist maintains Boston Scientific buy rating, $110 target - Investing.com
Boston Scientific to acquire Bolt Medical - Medical Buyer
Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m - Yahoo Finance
Boston Scientific Announces Planned Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio - GuruFocus.com
Boston Scientific Co. (NYSE:BSX) Shares Sold by International Assets Investment Management LLC - MarketBeat
Boston Scientific Co. (NYSE:BSX) Shares Acquired by Nordea Investment Management AB - MarketBeat
Here's What to Expect From Boston Scientific's Next Earnings Report - MSN
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):